European Archives - Page 539 of 1101 - European Medical Journal

EMJ Oncology 9 [Supplement 5] 2021

In this supplement to EMJ Oncology, two internationally renowned experts, Andres J. Muñoz Martin and Annie Young, explored risk assessment…

Trial Outcomes and Sub-Analyses of Direct Oral Anticoagulants in the Treatment of Cancer-Related Venous Thromboembolism: Interviews with Key Opinion Leaders

EMJ conducted interviews with two key opinion leaders and specialists in the prevention and treatment of cancer-related venous…

EMJ Nephrology 9 [Supplement 3] 2021 Feature Image

Unmet Medical Needs in Chronic-Kidney-Disease-Associated Pruritus

CKD-aP necessitates a differential diagnosis to ascertain that the itching a patient is experiencing is related to…

EMJ

EMJ Nephrology 9 [Supplement 3] 2021

PRURITUS is a common challenging symptom seen in chronic kidney disease (CKD). Approximately 40% of patients with end-stage renal…

Roundtable: A new dawn for data

How is the data revolution going to impact the marketing and medical functions?

Neuroprosthesis Restores Speech in Paralysed Man

Breakthrough “speech neuroprosthesis” has allowed a man with severe paralysis to communicate using sentences. Find out more

Can Cognitive Decline Predict Faster Bone Loss?

Novel research has demonstrated that cognitive decline measured over 5 years increases future fracture risk in women. Find out more

Rare Genetic Variant Leads to Six-Fold Increase in Diabetes Risk

New evidence has emerged linking the presence of a rare genetic variant to an increased risk of developing Type 2 diabetes mellitus.

Could Antidepressants Improve Outcomes for Sufferers of Diabetes and Depression?

Could antidepressants improve outcomes for sufferers of diabetes and depression? Read the article and find out more

The rare disease disparity

Some thoughts about how the Rare Disease Act impacted pharma and if it needs further updating after almost 20 years.